Sam's Club Pharmacy vs MarketAxess
Side-by-side comparison of AI visibility scores, market position, and capabilities
Walmart-owned warehouse club pharmacy with 500+ locations; bulk purchasing enables discounted $4/$10 generics competing with Costco Pharmacy as part of Walmart's health services strategy.
About
Sam's Club Pharmacy is the pharmacy division operating within Sam's Club warehouse membership clubs, providing prescription filling, immunizations, health screenings, and specialty pharmacy services to Sam's Club members at competitive pricing leveraging Walmart's pharmaceutical purchasing scale. Part of Walmart Inc. (NYSE: WMT), Sam's Club Pharmacy operates more than 500 pharmacy locations inside Sam's Club warehouse clubs across the United States, offering members discounted prescription pricing as part of the Sam's Club membership value proposition.\n\nSam's Club Pharmacy's competitive advantage lies in Walmart's massive pharmaceutical purchasing power — the combined Walmart/Sam's Club pharmacy network is one of the largest in the US, enabling negotiated drug pricing that can undercut traditional retail pharmacies. Members access prescriptions at Sam's Club prices with convenient access during their warehouse shopping trips. The pharmacy offers $4/$10 generic prescription pricing for common medications, mail-order options, and immunization services.\n\nIn 2025, Sam's Club Pharmacy operates within Walmart's broader health strategy — Walmart Health (primary care clinics) and Walmart+ pharmacy benefits are being integrated to create a comprehensive health services ecosystem for Walmart and Sam's Club customers. The retail pharmacy market faces structural challenges from pharmacy benefit manager (PBM) reimbursement pressure that has forced independent and chain pharmacy closures. Sam's Club Pharmacy competes with Costco Pharmacy (similar warehouse model), CVS, Walgreens, and mail-order PBM pharmacies. The 2025 strategy focuses on expanding specialty pharmacy capabilities, integrating prescription benefits with Walmart+ membership, and growing immunization and preventive health services.
New York electronic bond trading (NASDAQ: MKTX) $763M FY2024 revenue; Open Trading $2T+ liquidity, 40% US IG bond electronification, portfolio trading growth competing with Tradeweb and Bloomberg.
About
MarketAxess Holdings Inc. is a New York City-based electronic fixed income trading platform — publicly traded on the NASDAQ (NASDAQ: MKTX) as an S&P 500 Financials component — operating the leading electronic trading marketplace for US investment-grade corporate bonds, US high-yield bonds, emerging market bonds, municipal bonds, and US Treasury securities through approximately 850 employees globally. In fiscal year 2024, MarketAxess reported revenues of $763 million with record trading volumes in US investment-grade bonds and emerging market credit, as the multi-year electronification trend in bond markets continued to shift institutional fixed income trading from voice broker-dealer phone execution to electronic all-to-all trading on MarketAxess's Open Trading marketplace. CEO Chris Concannon (joined 2023, formerly Cboe Global Markets president) leads MarketAxess's strategy of expanding market share beyond the institutional investment-grade core into rate products (US Treasuries, agency securities), high-yield, and portfolio trading as fixed income electronification accelerates — currently approximately 40% of US investment-grade bonds trade electronically versus 15% in 2015. MarketAxess's Open Trading protocol (anonymous all-to-all price discovery between buy-side, sell-side, and market makers) generated over $2 trillion in liquidity provision in 2024, reducing transaction costs versus bilateral dealer quotes by an average of $0.28 per $100 face value.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.